{"nctId":"NCT02304484","briefTitle":"Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab","startDateStruct":{"date":"2014-11-24","type":"ACTUAL"},"conditions":["Hypercholesterolemia"],"count":770,"armGroups":[{"label":"Evolocumab","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab"]}],"interventions":[{"name":"Evolocumab","otherNames":["AMG 145","Repatha"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Completed week 80 of study 20120153 (NCT01813422).\n\nExclusion Criteria:\n\n* Did not complete investigational product in the 20120153 parent study\n* Have an unstable medical condition, in the judgment of the investigator\n* Known sensitivity to any of the products to be administered during dosing\n* Currently enrolled in another investigational device or drug study (excluding evolocumab (AMG 145) parent study), or less than 30 days since ending another investigational device or drug study(s),or receiving other investigational agent(s)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"99 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Adverse Events","description":"The severity of each adverse event (AE) was graded using the Common Terminology Criteria for Adverse Events (CTCAE) version 4.03 criteria, where Grade 1 = Mild AE, Grade 2 = Moderate AE, Grade 3 = Severe or medically significant AE, Grade 4 = Life-threatening consequences, and Grade 5 = death related to AE.\n\nAn adverse device effect was defined as any adverse event related to the use of a medical device (autoinjector/pen or automated mini doser \\[AMD\\]), including but not limited to, AEs resulting from insufficient or inadequate Instructions for Use, AEs resulting from any malfunction of the device, or AEs resulting from use error or from intentional misuse of the device.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"526","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"415","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"206","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"153","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-21.52","spread":"40.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-57.23","spread":"22.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-58.54","spread":"25.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-55.26","spread":"28.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.72","spread":"30.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-53.65","spread":"28.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.30","spread":"28.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.73","spread":"32.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-47.94","spread":"36.49"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":153,"n":770},"commonTop":["Hypertension"]}}}